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Abstract
Awareness of cognitive dysfunction shown by individuals with Mild Cognitive Impairment (MCI),
a condition conferring risk for Alzheimer’s disease (AD), is variable. Anosognosia, or unawareness
of loss of function, is beginning to be recognized as an important clinical symptom of MCI. However,
little is known about the brain substrates underlying this symptom. We hypothesized that MCI
participants’ activation of cortical midline structures (CMS) during self-appraisal would covary with
level of insight into cognitive difficulties (indexed by a discrepancy score between patient and
informant ratings of cognitive decline in each MCI participant). To address this hypothesis, we first
compared 16 MCI participants and 16 age-matched controls, examining brain regions showing
conjoint or differential BOLD response during self-appraisal. Second, we used regression to
investigate the relationship between awareness of deficit in MCI and BOLD activity during self-
appraisal, controlling for extent of memory impairment. Between-group comparisons indicated that
MCI participants show subtly attenuated CMS activity during self-appraisal. Regression analysis
revealed a highly-significant relationship between BOLD response during self-appraisal and self-
awareness of deficit in MCI. This finding highlights the level of anosognosia in MCI as an important
predictor of response to self-appraisal in cortical midline structures, brain regions vulnerable to
changes in early AD.
MeSH Terms
Magnetic Resonance Imaging; Self Assessment (Psychology); Agnosia; Alzheimer disease;
Neocortex; Aging
INTRODUCTION
Mild Cognitive Impairment (MCI), a condition conferring significant risk for Alzheimer’s
disease, is characterized by significant decline in memory and often other aspects of cognition.
Awareness of cognitive dysfunction shown by MCI patients is quite variable, ranging from
clear insight and marked concern about cognitive difficulties to severe anosognosia (Vogel et
al., 2004). Anosognosia can be defined as a patient’s unawareness of deficits resulting from
brain disease or injury. In its original use, the term anosognosia specified complete
unawareness of hemiplegia in stroke patients (Babinsky, 1914); however, use of this term has
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since expanded to denote attenuated awareness of varied sensory, motoric, and higher cognitive
deficits (Ansell & Bucks, 2006; Heilman et al., 1998). In this report, the terms anosognosia
and impaired awareness are used interchangeably to denote reduced ability to make realistic
or accurate appraisals regarding one’s current memory/cognitive ability. Our MCI participants
showed a wide range of reduced ability in this regard, and we use the term anosognosia to
denote a continuum of awareness deficits ranging from mildly limited to severely impaired.
The prevalence of impaired awareness, or anosognosia, may be underestimated in the MCI
literature because many researchers include the patient’s subjective memory complaint as a
criterion necessary for an MCI diagnosis. However, studies that do not include self-report of
memory complaints in their diagnostic criteria suggest that MCI patients show impaired
awareness approaching the level seen in AD (Duke et al., 2002; Vogel et al., 2005; Vogel et
al., 2004). Furthermore, anosognosia may be an important prognostic index, with research
indicating that MCI patients who lack awareness of functional deficits show greater conversion
to AD than those who show awareness (Tabert et al., 2002). These findings indicate that
diagnostic criteria requiring subjective memory complaint by the MCI patient may miss a
segment of the MCI population that is at high AD-risk. Although anosognosia is being
uncovered as an important clinical symptom of MCI, little is known about the brain substrates
of anosognosia in this patient group.
Functional brain imaging studies of neurologically-healthy adults have uncovered a
conglomerate of cortical midline structures involved in appraisal of self-relevant information
(for reviews see, Amodio & Frith, 2006; Northoff & Bermpohl, 2004; Northoff et al., 2006).
Specifically, orbitomedial (Brodmann’s areas (BA) 11, 12), ventromedial (BA 10),
dorsomedial (BA 9) prefrontal cortices (OMPFC, VMPFC, and DMPFC respectively) as well
as anterior cingulate cortex (BA 24, 25, 32) show activation during tasks requiring self-
referential judgments regarding trait adjectives (Fossati et al., 2003; Johnson et al., 2002;
Schmitz et al., 2004; Schmitz et al., 2006). Likewise, medial parietal regions such as
retrosplenial cortex (BA 26, 29, 30), posterior cingulate cortex (BA 23), and precuneus (BA
7, 31) show activation during these self-referential tasks, as well as during retrieval of
autobiographical memories (Johnson et al., 2002; Maddock et al., 2001; Schmitz et al., 2004;
Shah et al., 2001; Sugiura et al., 2005). Dysfunction in these medial cortical regions may
underlie the impaired awareness shown by a subset of MCI patients.
Although direct investigation of the functional brain substrates of anosognosia in MCI is sparse,
neuroimaging studies of other patient groups with compromised brain function (e.g., traumatic
brain injury, frontotemporal dementia, AD) implicate frontal lobe dysfunction in the
instantiation of anosognosia (Mendez & Shapira, 2005; Schmitz et al., 2006). Studies of AD
show a relationship between decreased perfusion and glucose metabolism in frontal regions
and decreased awareness of cognitive impairment (Harwood et al., 2005; Reed et al., 1993;
Salmon et al., 2005) as well as correlations between anosognosia and other frontal lobe
symptoms such as executive dysfunction and apathy (Derouesne et al., 1999; Lopez et al.,
1994; Michon et al., 1994; Ott et al., 1996). In the first imaging study of awareness to include
MCI patients, a combined group of MCI and early AD patients showed a significant correlation
between anosognosia and rCBF in bilateral frontal inferior gyri (Vogel et al., 2005). Results
of that study, together with reports of executive dysfunction and elevated frontally-mediated
symptoms (e.g., apathy) in MCI (Ready et al., 2003), suggest that MCI patients exhibit reduced
frontal lobe function, and this may relate to decreased self-awareness.
The potential role of medial parietal dysfunction in anosognosia seen in MCI is supported by
mounting empirical evidence implicating this region in self-referential processing together
with the vulnerability of this region to early AD-like changes. Investigations of resting brain
function indicate that medial parietal regions such as the posterior cingulate cortex (PCC) show
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metabolic decline in MCI (Nestor et al., 2003), and longitudinal studies indicate that PCC
metabolism and regional blood flow discriminate between individuals with MCI who soon
develop AD and those who do not (Anchisi et al., 2005; Chetelat et al., 2003; Huang et al.,
2002; Kogure et al., 2000). Additionally, fMRI studies of episodic recognition indicate that
MCI participants show less PCC activation than age-matched controls (Johnson et al., 2005;
Ries et al., 2006). However, results of one fMRI study suggest that MCI participants and age-
matched controls show comparable activity during self-appraisal in a PCC location (Ries et
al., 2006). In that study, the PCC was the sole location in which controls exhibited common
activation during self-appraisal and episodic recognition; MCI participants did not. Further
investigation of this PCC location indicated that MCI participants showed reduced BOLD
response during recognition; however, activity was similar to controls during self-appraisal.
Given evidence that healthy young adults show reliable PCC activity during self-referential
processing (Fossati et al., 2003; Kelley et al., 2002; Ochsner et al., 2004; Schmitz et al.,
2004) together with evidence that individuals with MCI are quite variable in their ability to
make accurate self appraisals (Vogel et al., 2004), one possible explanation for this prior result
is that PCC activity during self-appraisal is variable in MCI participants. It may be that MCI
participants with intact self-awareness may show PCC activity during a fMRI self-appraisal
task that is comparable to controls whereas MCI participants with anosognosia may show
attenuated PCC activity. In this case, a between group comparison (MCI vs age-matched
controls) of PCC activity during self-appraisal that does not account for MCI participants’ level
of anosognosia may not be sensitive to the changes occurring in a subset of this patient group.
The objective of the current fMRI study is to further investigate MCI participants’ brain activity
associated with self-referential processing. No investigation has assessed the relationship
between brain activity and level of awareness of cognitive difficulties shown by MCI
participants. We hypothesized that MCI participants’ activation of cortical midline structures
would covary with their level of insight into their cognitive difficulties.
To fully address this hypothesis, we first compared MCI participants and age-matched controls,
examining brain regions that were either conjointly or differentially active during self-appraisal
at a specific statistical threshold. Secondly, we used regression to investigate the relationship
between awareness of deficit and BOLD response during a self-appraisal fMRI task. Our
evaluation of participants’ level of awareness was based on a discrepancy score between two
parallel forms of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).
One form was given a relative or friend who had known the participant for 10 years or more
(Jorm, 2004). We devised a second form with identical questions that was administered to the
MCI participant. In contrast to studies of MCI and AD that have correlated resting metabolism
or perfusion with awareness scores, our assessment of brain function used a functional
neuroimaging paradigm requiring self-appraisal. This fMRI task reliably evokes cortical




Sixteen healthy elderly control participants and 16 individuals with MCI participated in this
study, and all research was completed in accordance with the guidelines of the Helsinki
Declaration (http://www.wma.net/e/policy/17-c_e.html). All participants received a battery of
neuropsychological tests as part of this study to verify and document the extent of any
impairment in memory and other aspects of cognitive function. Participants were compensated
$50.00 for time and travel. Table 1 contains descriptive demographic and neuropsychological
data for our participants. MCI patients were referred from the several memory disorders clinics
at a university-based medical center. Our diagnostic criteria for MCI were consistent with those
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proposed by Winblad et al. (2004), and they included: a) presence of memory complaints by
participant and/or informant, b) cognitive deficits on memory testing together with subjective
report of decline over time by participant and/or information, c) intact functional status, d)
cognitive and functional status not consistent with a diagnosis of dementia. All MCI
participants were accompanied by an informant. All MCI participants were classified as
amnestic on the basis of objective cognitive testing, with twelve participants showing selective
memory impairment (i.e., amnestic MCI, single domain; Gauthier et al., 2006), and four
showing impairment of memory and another aspect of cognition (i.e., amnestic MCI, multiple
domains. According to the reports of participants and informants, no participant showed
evidence of decline in activities of daily living. Prior to inclusion in this study, the MCI patients
were presented to a diagnostic consensus panel consisting of medical professionals involved
in the participants' patient care, geriatricians, and neuropsychologists for support of the
diagnosis. All 16 MCI participants were taking cholinesterase inhibitors, with dosage being
stable for three months prior to study participation.
Elderly control participants were recruited from the community, predominantly by
advertisement, mailings, and community outreach events. These participants exhibited normal
performance across cognitive domains assessed by neuropsychological testing.
Exclusion criteria for all participants included Hachinski score greater than four, prior
neurological disease or neurosurgery, report of a present or prior major psychiatric disorder,
chronic major medical conditions such as insulin-dependent diabetes, poorly controlled
hypertension, or cardiac disease. Participants' current mood was assessed with the Center for
Epidemiologic Study – Depression Scale and the State-Trait Anxiety Inventory. Participants
showing evidence of significant distress (CES-D > 16; STAI trait scale in >95th percentile of
age & sex-corrected normative data) were excluded from this study (Radloff, 1977;
Spielberger, 1983; Weissman et al., 1977). We also obtained T2-weighted images as described
below to screen for previously undetected clinically relevant brain abnormalities.
In order to determine the areas of the brain normally active during this task we also administered
our task to a reference group consisting of 105 cognitively normal, physically healthy adults
ranging in age from 18 to 84 who were recruited from the University of Wisconsin, from the
community via advertisement and public outreach events, and through existing registries of
healthy adults who had previously expressed willingness to participate in aging research (mean
age = 46.2, S.D.=16.2; mean education 15.8 (2.5); 37 Males, 68 Females).
Procedures
Neuropsychological Assessment—All participants received a neuropsychological test
battery assessing general mental status (Mini Mental Status Examination) (Folstein et al.,
1975), an estimate of pre-morbid cognitive ability (Wide Range Achievement Test- 3rd Edition)
(Jastak Associates, 1993), simple and shifting attention (Trails A & B), visual and verbal
memory (Brief Visuospatial Memory Test, Revised (Benedict, 1997); Rey Auditory Verbal
Learning Test), semantic and phonemic fluency (Animal Naming and Controlled Oral Word
Association Test), confrontation naming (Boston Naming Test, 2nd Edition (Kaplan et al.,
2001)), and visuospatial ability (Judgement of Line Orientation).
Measure of Anosognosia—Each participant’s level of awareness was indexed by a
discrepancy score between two parallel forms of the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE). One form was given to a relative or friend who had known
the participant for 10 years or more (Jorm, 2004). We devised an identical form to be given to
the MCI participant. Both forms of the IQCODE contain 16 items on which one rates cognitive
change over the past 10 years on a scale of 1 (“much improved”) to 5 (“much worse”). The
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discrepancy score was obtained by subtracting each participant’s average rating from the
average rating of the informant.
fMRI Task—The task has been described in detail elsewhere (Ries et al., 2006; Schmitz et
al., 2006). The self-appraisal fMRI task consisted of an experimental (self) condition and a
baseline (semantic) condition. In the self condition, trait adjectives were presented (e.g., calm,
obnoxious, sharp, trusting, creative), and participants made quick yes/no decisions about
whether each word described them by means of a button press. In the semantic condition,
participants were presented with the same trait adjectives seen during the self condition (order
of presentation was counterbalanced across conditions); however, they were asked to indicate
whether each word was positive in valence or not. In both self and semantic decision conditions
of the self-appraisal task, adjectives were presented every 4,000 ms, remaining on screen for
3,000 ms followed by a 1,000 ms second inter-stimulus interval. An index finger button press
indicated “no” and the middle finger indicated “yes.”
Two alternate forms of the task with identical timing were presented sequentially (order was
counterbalanced) using a discrete 30-adjective set. Within each form, items from each of the
two conditions were presented in five pseudo-randomized cycles. Adjectives were presented
in blocks of six per condition. The two different conditions each appeared in a slightly different
color text, and there were prompts at the top of the screen to inform participants about the
condition to which they should respond on each trial. The task duration for each form of the
task was four minutes and eight seconds.
Scanning Procedures—Participants were provided with instruction on the fMRI tasks and
underwent practice prior to scanning. They were then situated on the bed of a GE long bore
3.0 Tesla MRI scanner and outfitted with the MR-compatible button-box and a high-resolution
goggle system, set at 800 × 600 from Resonance Technology (Northridge, CA, USA). Head
motion was constrained by foam padding. The software Presentation (www.neuro-bs.com) was
used to deliver visual stimuli from a personal computer via the goggle system and also record
responses. A cable connecting the scanner to the presentation computer enabled the stimulus
delivery software to be triggered by the start of the scan and also detect each slice acquisition
for precise synchrony between scan acquisition and stimulus delivery.
Imaging Protocol—A T2* gradient-echo, echo-planar imaging (EPI) pulse sequence was
used. The homogeneity of the static magnetic field (B0) in the brain was optimized using higher
order shims prior to the functional trials. The EPI parameters for both tasks were as follows:
echo time (TE) = 30 ms; repetition time (TR) = 2000 ms; flip angle = 90 degrees; acquisition
matrix = 64 × 64 voxels; field of view (FOV) = 240 mm. Thirty sagittal slices of brain were
acquired within each TR. Voxel resolution was 3.75 × 3.75 × 5 mm (4mm thick slices with a
1 mm skip). 124 temporal volume images were collected. The first three frames of each time-
series were discarded.
Although we used higher order shimming for the EPI scans, there are typically residual
magnetic field (B0) inhomogenities across the brain that cause regional image distortions in
echo planar images such as near the mesial temporal lobe and in the frontal and ethmoid sinuses.
Image distortions were corrected by measuring 3D field maps across the brain (co-planar with
the fMRI slices). This was accomplished by measuring the phase of non-EPI gradient echo
images at two echo times (7 and 10 ms). The phase difference between the two echo images
is proportional to the static field inhomogeneity (Jezzard & Balaban, 1995). The field map
correction was calculated and applied by algorithms (“prelude” and “fugue”) (Jenkinson,
2003) that are part of the FSL software package created by the Image Analysis Group, FMRIB,
Oxford, UK. This program estimates the continuous B0 field map; image unwarping is
performed using a nonlinear pixel shifting and B splines interpolation algorithm.
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Following the functional scans and field mapping, a T1 weighted inversion recovery prepared
volume and T2 weighted anatomic images were acquired. A 3D inversion recovery prepared
fast gradient-echo pulse sequence provided high-resolution T1-weighted structural images
with the following parameters: inversion time = 600 ms; fast gradient-echo read-out with TR
= 9 ms; TE = 1.8 ms, flip angle = 20°; acquisition matrix = 256 × 192 × 124 (interpolated to
256 × 256 × 124); field of view = 240 mm; slice thickness = 1.2 mm (124 slices); ± 16kHz
receiver bandwidth.
A fast-recovery fast-spin echo 2D T2-weighted axial sequence was also acquired with the same
start and stop locations as the T1-weighted images. The parameters were as follows: field of
view = 240 mm; matrix = 256 × 256; TR = 9000 ms; TE = 93 ms; flip angle = 90°. Seventy
slices were acquired; slice thickness = 1.7 mm with 0.3 mm skip. A neuroradiologist reviewed
all images before data analysis for abnormalities that were inconsistent with the diagnosis and/
or requiring clinical follow-up.
Image Processing and Statistics
Functional MRI Analysis: Following EPI image reconstruction the 4D image time-series was
motion-corrected to overcome minor head movement during the scan (only individuals with
<3 mm movement in the x, y, and z planes were included in this report). The field map from
each subject was then applied to each image in the time series. This was followed by spatial
normalization into a standard atlas space (using the T2* weighted template) resampling to 2
mm isotropic voxels and spatial smoothing to 8 mm.
Statistical Parametric Mapping software (SPM2) was used for statistical analysis at the single
subject level (K. Friston et al., 1995). Analyses of the time series data were performed on
individual participants using a boxcar model convolved with the canonical hemodynamic
response function. Low-frequency components of the fMRI data were removed through use of
a 128 second high-pass filter. We employed the AR1 method of estimating temporal
autocorrelation in the time series (K. J. Friston et al., 2000). The contrast SELF>SEMANTIC
was computed for each participant, and these contrasts were taken to second level analysis.
For group-level analyses we constructed two regions of interest, constraining subsequent
analyses to the regions of hypothesized difference in activation. These ROI’s were derived
from results of a one-sample t-test for the large reference group (FDR thresholding p<.05).
Significant activation from the reference group within the medial prefrontal cortex (MPFC)
constitutes the MPFC explicit mask, and activation within the medial parietal region constitutes
the PCC explicit mask.
Using group random-effects procedures, we investigated regions of conjoint and differential
activation across the MCI and control groups. A conjunction analysis was conducted to evaluate
common regions of brain activation across the MCI and control groups. We employed the
conjunction null method (Nichols et al., 2005). To evaluate regions showing differential
activation between groups, we conducted a 2-group t-test.
An additional random-effects analysis allowed us to assess the hypothesis that self awareness
would be a significant predictor of activation of cortical midline structures in MCI participants.
Using linear regression analysis in SPM2 we assessed IQCODE discrepancy scores as a
predictor of activation. In order to determine whether this relationship was independent of the
severity of memory impairment, we included an index of learning (i.e., total number of items
learned across trials on the Rey Auditory Verbal Learning Test (RAVLT)), as a covariate of
no interest in this regression analysis.
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Voxel Based Morphometry: The T1 volume was used for voxel-based morphometry (VBM)
to determine whether there were volumetric differences between MCI participants and controls
that might account for any observed fMRI differences. The VBM analysis used a standard
approach (Good et al., 2001). The normalization parameters were re-applied to the original
image that was re-sampled using B-splines interpolation to a voxel size of 2 mm3. The
normalized brain image was then segmented and the resulting GM images were modulated
using the Jacobian values obtained from the spatial normalization in order to preserve GM
volume. In the final step, the modulated images were smoothed using a 12-mm isotropic
Gaussian kernel. A t-test was used to determine whether there were group differences in gray
matter. We further examined MCI participant data, using linear regression to assess the
IQCODE discrepancy score as a predictor of gray matter.
RESULTS
Behavioral Results
Self-appraisal Task—Reaction time data for the self-appraisal task is summarized in Table
1. Between group t-test comparisons revealed no group difference in reaction time in either
condition of this task.
IQCODE and other Neuropsychological Measures—Performance on a battery of
neuropsychological measures is depicted in Table 1. Standard scores reported in Table 1 were
based on the Mayo's Older Americans Normative Studies (MOANS) normative data (R. Ivnik
et al., 1996;R. J. Ivnik et al., 1992) and other test-specific normative data (Benedict,
1997;Jastak Associates, 1993;Tombaugh et al., 1999). One control participant completed all
tests except for MMSE and Animal Naming. Consistent with expected cognitive results,
individuals with MCI showed significantly poorer performance across a number of cognitive
domains. MCI participants showed significantly poorer general mental status (MMSE), t (29)
= 13.19, p < 0.001. Group memory differences were found on indices of verbal learning
(RAVLT total trials 1–5), t (30) = 5.05, p < 0.001, verbal recall (RAVLT delayed recall), t (30)
= 6.22, p < 0.001, visuospatial learning (BVMT-R total trials 1–3), t (30) = 6.74, p < 0.001,
and visuospatial recall (BVMT-R delayed recall), t (30) = 7.87, p < 0.001. MCI participants
also showed significant poorer performance on timed measures of shifting attention (Trails B),
t (30) = −2.46, p < 0.05, phonemic fluency (COWAT), t (30) = 2.02, p < 0.05, and semantic
fluency (Animal Naming), t (29) = 2.41, p < 0.05. In contrast, no group differences were found
on measures of reading skill (WRAT-III Reading), simple attention and processing speed
(Trails A), confrontation naming (BNT-II), or visuospatial ability (JLO), p > 0.05.
IQCODE ratings are also reported in Table 1. Informants rated MCI participants as
demonstrating significantly more cognitive decline than control participants, t(30) = −5.64, p
< 0.001. However, analysis of self-ratings of MCI participants and control participants revealed
no significant group difference, p > 0.05. Between group analysis indicated that IQCODE
discrepancy scores were greater for MCI participants than controls, t(30) = −3.61, p < 0.001.
There was no significant correlation between the IQCODE discrepancy score and any of the
other neuropsychological measures administered and listed in Table 1 (for all correlations, p
>.05).
To further characterize patients' and informants' IQCODE responses, we tallied their ratings.
Seven MCI participants reported that cognitive and/or functional status had remained constant
over the past ten years (i.e., average rating of 2–3); seven indicated slight change (average
rating of 3–4); two indicated substantial change (average rating of 3–4). Tallying informant
ratings showed that two indicated not observing much change in the MCI participant, seven
indicated slight change, and seven indicated substantial change. As depicted in Figure 1, some
participant-informant pairs showed similar IQCODE ratings. However, other pairs of
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participant-informant ratings were discrepant, with informants generally endorsing greater
decline than participants. Group analysis showed no significant correlation between participant
and informant ratings (r=0.31, p<0.05)
Imaging Results
Reference Group—Figure 2 and Table 2 depict the cerebral response during self-appraisal
in the reference group. Significant activation to self items was present in ventral and dorsal
aspects of the medial frontal lobe as well as in the posterior cingulate region (FWE < .05).
These two large regions were used to constrain the group comparisons as well as the regression
analysis.
MCI and Control Groups: Conjunction Analysis—Figure 3a–b presents a sagittal view
of midline brain regions showing activation in controls and MCI participants during self-
appraisal at an uncorrected threshold of p<0.005. Regions showing a conjunction of activity
across participants (p unc < 0.005) are also depicted in Figure 3c. These regions of activation
are also explicated in Table 3. The conjunction across groups was not present at a more rigorous
statistical threshold of FDR < 0.05.
MCI and Control Groups: 2-group t-test—Figure 3d presents a sagittal view of midline
brain regions showing greater activation in controls than MCI participants during self-appraisal
at an uncorrected threshold of p<0.005. These regions of differential activation are also
explicated in Table 3. The group difference was not significant at a more rigorous statistical
threshold of FDR < 0.05. No brain regions were significantly more active in MCI participants
than controls.
MCI Group Activation: Association with Rating of Self-Awareness—We conducted
a regression analysis, explicitly masking MPFC and medial parietal cortex, to examine the
hypothesis that self-awareness (indexed by IQCODE difference score) is a significant predictor
of CMS activity in MCI participants. Using an FDR-corrected p-value threshold of 0.05,
regression analysis revealed a significant negative relationship between IQCODE difference
score and activation during self-appraisal in both medial prefrontal and posterior cingulate
regions (depicted in Table 4). RAVLT learning performances were included as a covariate of
no interest in the analysis; thus, the association between awareness and BOLD signal in these
regions does not appear to relate to the MCI participants’ level of predominant cognitive
impairment. We also examined the relationship between IQCODE discrepancy score and fMRI
response in the control group and found no significant association (punc > 0.05).
To graphically-depict the correlation described above for the MCI participants, we extracted
VOI’s based on the MPFC and PCC clusters that were significant in the regression analysis.
Figure 4 plots the significant relationship between the first eigenvariate for the MPFC VOI and
the participants’ IQCODE difference scores (r = −0.86, FDR-corrected p < 0.05). Figure 5
plots the significant relationship between the first eigenvariate for the PCC VOI and IQCODE
difference scores (r = −0.75, FDR-corrected p <0.05).
Volumetric Analysis—To ensure that fMRI signal was not affected by differences in brain
atrophy, voxel-based analyses of gray matter volume were performed using the models
employed in the functional analyses. There was no significant difference between MCI
participants and age-matched controls, even at a liberal threshold (p < .001 uncorrected). Within
the MCI group, gray matter volume did not significantly covary with IQCODE difference
scores (p < .001 uncorrected).
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Our results reinforce the finding that cortical midline structures are involved in self-referential
processing, and they indicate that a self-appraisal fMRI task is sensitive to functional brain
changes associated with impaired insight in MCI. Consistent with our primary hypothesis, MCI
participants showed variable insight into their cognitive difficulties, and those MCI participants
with less insight showed significantly attenuated activation in MPFC and PCC during self-
appraisal. Our results suggest that the regional correlations between BOLD activation and level
of self-awareness were not related to the MCI participants’ level of cognitive impairment. The
correlations are robust even when an index of memory performance is included as a covariate
in the regression analysis, and furthermore, our index of awareness in MCI participants was
not correlated with their cognitive performance. Our results also suggest that the correlation
between BOLD response and awareness was not attributable to variation in brain volume. A
voxel-based analysis of gray matter volume showed that our MCI participants showed no
differences when compared to a group of age-matched controls, and gray matter volume was
not significantly related to awareness scores.
Consistent with prior findings, results of the conjunction analysis suggest that as a group, MCI
participants show areas of cortical midline activity that are comparable to controls at an
uncorrected threshold. Results of a between-group t-test indicate that MCI participants show
attenuated activity in some neighboring cortical midline regions although this group difference
is significant only at a liberal, uncorrected threshold. Because of possible Type 1 error, these
findings should be interpreted with caution. Importantly, one possible reason for these
minimally-significant results would be that MCI participants show heterogeneous CMS
activity during self-appraisal. This idea motivated our main analyses examining the
relationship between accuracy of self-appraisal and CMS activity in the MCI group.
Although the results described above suggest that as a group, MCI participants show only
minimally attenuated activity on a self-appraisal task, our follow-up regression analyses reveal
a source of variability in the MCI group’s BOLD response. The significant correlation between
accuracy of self-referential judgments and CMS activity during self-appraisal in our MCI
participants suggests that dysfunction in CMS regions is linked to anosognosia for cognitive
deficit in this patient group.
The relationship between anosognosia and brain activity in MCI has received little empirical
attention. The current cross-sectional study suggests that a fMRI self-appraisal task is sensitive
to brain changes associated with anosognosia in the MPFC and PCC, two brain regions that
are vulnerable to AD-like changes. A key question for future MCI research will be whether
the magnitude of BOLD response during self-appraisal is a sensitive predictor of conversion
to AD. Prior research suggests that anosognosia in MCI portends a faster rate of conversion to
AD (Tabert et al., 2002). Additionally, PCC resting glucose metabolism and perfusion have
been cited as prognostic indices of faster progression to AD (Anchisi et al., 2005; Huang et al.,
2002; Kogure et al., 2000). Longitudinal follow-up of the current findings is needed to address
the hypothesis that attenuated activity in cortical midline structures associated with
anosognosia is predictive of faster cognitive and functional decline in MCI. Furthermore, fMRI
tasks that directly query self-appraisal of areas of cognitive impairment may be quite useful in
the study of anosognosia. These data are currently being collected in our lab.
The precise definition of and neuropsychological criteria for MCI have been a source of
controversy (Davis & Rockwood, 2004; Manly et al., 2005), and diagnostic criteria continue
to shift over time to accommodate burgeoning research findings (Gauthier et al., 2006;
Petersen, 2004). One source of controversy regarding MCI diagnosis relates to the criterion of
a self-reported memory complaint. Results of the current study suggest that MCI patients have
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widely-varying awareness of their cognitive deficits. Thus, diagnostic decisions including the
criterion of patient report of memory decline are likely to miss a large segment of the MCI
population, perhaps those patients who are at particularly high risk for conversion to AD. It is
clearly important to document an MCI patient's memory impairment as a decline from previous
function (as opposed to a long-standing cognitive impairment) (Petersen, 2004), and thus, the
subjective report of function is a critical aspect of the MCI diagnosis. Importantly, the current
findings and results of other research suggest that the ideal individual to consult regarding
cognitive decline would be an informant who has been in regular contact with the patient for
several years (Vogel et al., 2004).
The current study is limited by small sample size, limiting our power to detect statistical effects.
Because of this limitation, we restricted our correlation analysis to cortical midline regions
chosen in an apriori hypothesis-driven fashion that have been shown to be normally-responsive
on the self-appraisal task in a reference group of younger adults. This approach focused the
analysis and helped to reduce the possibility of making spurious inferences due to Type I errors.
The drawback to this approach is that we were unable to examine any possible compensatory
brain activity that may have occurred outside of the explicitly-masked regions.
Another potential limitation of the current study relates to our measure of anosognosia: a score
reflecting the difference in each MCI participant’s self-rating and a rating given by a close
family member or friend. We were careful to select informants who had known the MCI
participants for over 10 years and who had regular contact with them. Despite this careful
selection, informants may have varied with respect to personal bias toward the MCI participants
(i.e., tendency to over- or underreport symptoms), and informants may have had varying
degrees of knowledge regarding the participants’ level of cognitive deficit.
Conclusion
The current paper focuses on an often overlooked aspect of the symptomatology of Mild
Cognitive Impairment: accurate appreciation of one's cognitive impairment. Our findings
reinforce the notion that individuals with MCI are quite heterogeneous with respect to their
ability to make accurate self-appraisals of cognitive ability. Furthermore, level of anosognosia
in MCI is strongly correlated with the BOLD response of frontal and parietal cortical midline
structures that are involved in self-appraisal and that are vulnerable to changes associated with
early AD.
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Plot depicting variability in the correspondence between patient and informant ratings on the
IQCODE scale. The correlation between patient and informant ratings is non-significant (r =
0.31, p = 0.24).
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Statistical parametric map of the BOLD signal change to self-appraisal condition in reference
group of 105 healthy young adults (p FWE < .05)
Ries et al. Page 15














Statistical parametric map of the BOLD signal change to self-appraisal condition in (a) non-
impaired older adults and (b) individuals with mild cognitive impairment; (c) Regions of
common activation between groups as determined by conjunction analysis; (d) Regions
showing less activation in individuals with mild cognitive impairment. Statistical threshold for
all contrasts was p unc < 0.005.
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Participants with Mild Cognitive Impairment: Plot of the negative correlation (r = −0.83,
pFDR < 0.05) between BOLD signal change during self-appraisal and IQCODE difference score
in ventral MPFC cluster.
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Participants with Mild Cognitive Impairment: Plot of the negative correlation (r = −0.76,
pFDR < 0.05) between BOLD signal change during self-appraisal and IQCODE difference score
in PCC of MCI participants.
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